undamentalytics Newsletter
Sign in

Funds (13F)

Marsico Capital Management LLC

Backtest from 23 Aug 2013 to 2 Nov 2026 · weekly · hypothetical

Watch this strategy
Return a year
+17.1%
S&P 500 +14.1%
Last 12 months
+5.1%
S&P 500 +12.1%
Sharpe ratio
0.79
S&P 500 0.78
Biggest drop
−39.6%
S&P 500 −31.8%
$10.0k$20.0k$40.0k$80.0k 2013201520172019202120232025 $80.0k$56.8k
StrategyS&P 500 $10,000 in Marsico Capital Management LLC from 23 Aug 2013 against the S&P 500 (total return) over the same dates, marked weekly, log scale. Hypothetical: before taxes and trading costs.

About

Copies Marsico Capital Management LLC's quarterly 13F holdings in the companies we cover, weighted by reported value: it buys on the first trading day after each 13F is filed (up to 45 days after the quarter) and holds until the next filing. A 13F shows long US-listed positions only, at the quarter's end, so this misses shorts, cash, bonds, non-US holdings and trading within the quarter.

Marsico Capital Management LLC's 13F holdings →

Key statistics

MeasureStrategyS&P 500
Return a year (compound)+17.1%+14.1%
Total return+700%+468%
Last 12 months+5.1%+12.1%
Last 3 months−2.9%—
Last month−5.1%—
This year so far+4.2%—
Volatility a year20.1%16.0%
Sharpe ratio0.790.78
Biggest drop−39.6%−31.8%
Beta to the S&P 5001.151.00
Alpha a year (t-statistic)+1.4% (0.64)—
Share of weeks up57%—

Sharpe ratio uses returns above the 3-month Treasury bill rate. Alpha is the yearly return left after allowing for the strategy's exposure to the S&P 500 (CAPM); a t-statistic below about 2 means it cannot be told apart from luck.

Insights

CompanyWeightHeld sinceReturn since
TSM6.7%——
NVDA6.3%——
GE5.5%——
AMZN5.3%——
AAPL4.9%——
GEV4.8%——
MU4.6%——
GOOGL4.5%——
ASML4.5%——
GS3.7%——
MSFT3.2%——
META3.1%——
BA3.0%——
LLY2.9%——
C2.8%——
COST2.3%——
VIK2.2%——
V1.5%——
RVMD1.1%——
MKSI1.0%——
CCEP1.0%——
TEVA1.0%——
AIR0.9%——
APH0.9%——
TLN0.8%——
VSEC0.8%——
HEI0.8%——
SHW0.8%——
TKO0.8%——
DDOG0.8%——
UAL0.8%——
SAP0.8%——
AME0.7%——
EVR0.7%——
URI0.7%——
KLAC0.7%——
YUM0.7%——
LRCX0.7%——
U0.7%——
ORLY0.7%——
SOLS0.6%——
ARES0.6%——
CTAS0.6%——
AXON0.6%——
SPOT0.5%——
AJG0.5%——
JCI0.5%——
JPM0.5%——
H0.5%——
DASH0.4%——
MTSI0.4%——
NBIS0.4%——
LITE0.4%——
MA0.4%——
CBRE0.4%——
INSM0.4%——
FIVE0.3%——
EWBC0.3%——
GOLF0.3%——
AVGO0.2%——
LIN0.2%——
IMAX0.2%——
ARM0.2%——
TSLA0.2%——
AMD0.2%——
MCD0.2%——
RACE0.2%——
WSO0.2%——

Weighted by reported value in the latest 13F, held until the next filing.

PeriodReturn a yearS&P 500SharpeS&P 500Biggest dropBetaAlpha (t)
Whole backtest23 Aug 2013 to 2 Nov 2026+17.1%+14.1%0.790.78−39.6%1.15+1.4% (0.64)
2018 onwards5 Jan 2018 to 2 Nov 2026+16.5%+13.9%0.660.66−39.6%1.17+1.2% (0.42)
Last three years3 Nov 2023 to 2 Nov 2026+24.7%+21.8%1.001.16−23.4%1.30−1.6% (−0.37)
Last year7 Nov 2025 to 2 Nov 2026+8.4%+14.2%0.330.84−11.2%1.26−7.1% (−1.06)
DateCompanyAction
14 Aug 2026YUMBought
14 Aug 2026TSLABought
14 Aug 2026TLNBought
14 Aug 2026SOLSBought
14 Aug 2026RACEBought
14 Aug 2026MKSIBought
14 Aug 2026LLYBought
14 Aug 2026INSMBought
14 Aug 2026HBought
14 Aug 2026EWBCBought
14 Aug 2026DDOGBought
14 Aug 2026AXONBought
14 Aug 2026ARESBought
14 Aug 2026AMDBought
14 Aug 2026AJGBought
15 May 2026VIKBought
15 May 2026NBISBought
15 May 2026MUBought
15 May 2026MCDBought
15 May 2026LRCXBought
15 May 2026LITEBought
15 May 2026KOBought
15 May 2026JCIBought
15 May 2026ARMBought
13 Feb 2026WMTBought

Dated at the rebalance that made the change.

DateCompanyAction
14 Aug 2026WMTSold
14 Aug 2026TXRHSold
14 Aug 2026RYAAYSold
14 Aug 2026ROLSold
14 Aug 2026NFLXSold
14 Aug 2026KOSold
14 Aug 2026CMGSold
14 Aug 2026CHRWSold
14 Aug 2026BURLSold
14 Aug 2026ALHCSold
15 May 2026ULTASold
15 May 2026TTWOSold
15 May 2026TTANSold
15 May 2026TSLASold
15 May 2026SNAPSold
15 May 2026SHOPSold
15 May 2026RYANSold
15 May 2026RBLXSold
15 May 2026PLTRSold
15 May 2026MLMSold
15 May 2026MCOSold
15 May 2026LLYSold
15 May 2026LEUSold
15 May 2026ISRGSold
15 May 2026FERGSold

Dated at the rebalance that made the change.

Backtests are hypothetical and use today's listed companies only, which flatters results. Past performance does not predict future returns. This is research, not investment advice. How we backtest